A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours by Horsley, L, Cummings, J, Middleton, M, Ward, T, Backen, A, Clamp, A, Dawson, M, Farmer, H, Fisher, N, Halbert, G, Halford, S, Harris, A, Hasan, J, Hogg, P, Kumaran, G, Little, R, Parker, G, Potter, P, Saunders, M, Roberts, C, Shaw, D, Smith, N, Smythe, J, Taylor, A, Turner, H

A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours. by Horsley, L, Cummings, J, Middleton, M, Ward, T, Backen, A, Clamp, A, Dawson, M, Farmer, H, Fisher, N, Halbert, G, Halford, S, Harris, A, Hasan, J, Hogg, P, Kumaran, G, Little, R, Parker, G, Potter, P, Saunders, M, Roberts, C, Shaw, D, Smith, N, Smythe, J, Taylor, A, Turner, H

Follow up of GW170817 and its electromagnetic counterpart by Australian-led observing programmes by Andreoni, I, Ackley, K, Cooke, J, Acharyya, A, Allison, JR, Anderson, GE, Ashley, MCB, Baade, D, Bailes, M, Bannister, K, Beardsley, A, Bessell, MS, Bian, F, Bland, PA, Boer, M, Booler, T, Brandeker, A, Brown, IS, Buckley, DAH, Chang, S-W, Coward, DM, Crawford, S, Crisp, H, Crosse, B, Cucchiara, A, Cupak, M, de Gois, JS, Deller, A, Devillepoix, HAR, Dobie, D, Elmer, E, Emrich, D, Farah, W, Farrell, TJ, Franzen, T, Gaensler, BM, Galloway, DK, Gendre, B, Giblin, T, Goobar, A, Green, J, Hancock, PJ, Hartig, BAD, Howell, EJ, Horsley, L, Hotan, A, Howie, RM, Hu, L, Hu, Y, James, CW